Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye

There have been enormous advances in the past decade for the treatment of age-related macular degeneration (AMD); however, these treatments are expensive and require frequent follow-up and injections which place a tremendous burden on both the healthcare system and patients. Consequently, there remains considerable interest in preventing or slowing the progression of AMD requiring treatment. Epidemiological studies have shown that diet is a modifiable AMD risk factor, and nutrient modification is a particularly appealing treatment for AMD due to the perceived universal benefit and relatively low expense. Recently, the age-related eye disease study part two (AREDS2) was concluded and demonstrated further benefit with the addition of lutein and zeaxanthin as a replacement for the β-carotene of the previous generation formulation. The addition of omega-3 essential fatty acids did not show an added benefit. This review aims to highlight some of the evidenced based body of knowledge that has been accumulated from recent studies regarding the use of nutritional supplements and their effect on AMD, cataracts, and dry eyes.

[1]  W. Willett,et al.  The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.

[2]  R. Elston,et al.  Oral zinc in macular degeneration. , 1988, Archives of ophthalmology.

[3]  B. Munoz,et al.  Ultraviolet light exposure and risk of posterior subcapsular cataracts. , 1989, Archives of ophthalmology.

[4]  P. Weber,et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.

[5]  L. J. Wei,et al.  Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .

[6]  R. Klein,et al.  Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. , 1992, American journal of public health.

[7]  P. Taylor,et al.  The Linxian cataract studies. Two nutrition intervention trials. , 1993, Archives of ophthalmology.

[8]  R. Klein,et al.  The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision. The Beaver Dam Eye Study. , 1994, Ophthalmology.

[9]  W. White,et al.  Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. , 1995, The American journal of clinical nutrition.

[10]  J. Manson,et al.  Body mass index. An independent predictor of cataract. , 1995, Archives of ophthalmology.

[11]  K. Yeum,et al.  Measurement of carotenoids, retinoids, and tocopherols in human lenses. , 1995, Investigative ophthalmology & visual science.

[12]  J. García-Sánchez,et al.  Effects of estrogen use on lens transmittance in postmenopausal women. , 1997, Ophthalmology.

[13]  P. Wilson,et al.  Cigarette smoking and the risk of development of lens opacities. The Framingham studies. , 1997, Archives of ophthalmology.

[14]  R. Klein,et al.  Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. , 1998, American journal of ophthalmology.

[15]  L T Chylack,et al.  Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. , 1998, Ophthalmology.

[16]  P. Wilson,et al.  A longitudinal study of body mass index and lens opacities. The Framingham Studies. , 1998, Ophthalmology.

[17]  A. Libunao Cigarette smoking and the risk of development of lens opacities , 1998 .

[18]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[19]  P. Weber,et al.  The benefits and risks of n-3 polyunsaturated fatty acids. , 1998, Bioscience, biotechnology, and biochemistry.

[20]  S. Richer,et al.  Nutritional and Environmental Influences on the Eye , 2000 .

[21]  M. Boulton,et al.  The role of oxidative stress in the pathogenesis of age-related macular degeneration. , 2000, Survey of ophthalmology.

[22]  S. Richer Nutritional and Environmental Influences on the Eye , 2000 .

[23]  R. Cumming,et al.  Use of vitamin supplements and cataract: the Blue Mountains Eye Study. , 2001, American journal of ophthalmology.

[24]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[25]  P. Calder,et al.  Polyunsaturated fatty acids, inflammation, and immunity , 2001, Lipids.

[26]  K. Yeum,et al.  Carotenoid bioavailability and bioconversion. , 2003, Annual review of nutrition.

[27]  M. Hambidge Underwood Memorial Lecture: human zinc homeostasis: good but not perfect. , 2003, The Journal of nutrition.

[28]  J. Manson,et al.  A randomized trial of beta carotene and age-related cataract in US physicians. , 2003, Archives of ophthalmology.

[29]  M. C. Leske,et al.  Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. , 2004, Archives of ophthalmology.

[30]  Catherine A McCarty,et al.  Vitamin E supplementation and cataract: randomized controlled trial. , 2004, Ophthalmology.

[31]  M. Sampson,et al.  Effects of omega-3 fatty acids on eye health. , 2005, Evidence report/technology assessment.

[32]  J. Buring,et al.  Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. , 2005, The American journal of clinical nutrition.

[33]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[34]  N. Congdon,et al.  The association between myopia and various subtypes of lens opacity: SEE (Salisbury Eye Evaluation) project. , 2005, Ophthalmology.

[35]  F. Brignole,et al.  [Improvement of dry eye symptoms with polyunsaturated fatty acids]. , 2006, Journal francais d'ophtalmologie.

[36]  M. Sampson,et al.  Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. , 2006, Ophthalmology.

[37]  F. Ferris,et al.  Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21. , 2006, Ophthalmology.

[38]  M. Srinivasan,et al.  The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India , 2006, British Journal of Ophthalmology.

[39]  R. Klein,et al.  Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.

[40]  W. Harris,et al.  Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults , 2008, Current atherosclerosis reports.

[41]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[42]  D. Jenkins,et al.  Fish oil and omega-3 fatty acids , 2008, Canadian Medical Association Journal.

[43]  F. Ferris,et al.  A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. , 2008, Ophthalmology.

[44]  M. Macsai The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). , 2008, Transactions of the American Ophthalmological Society.

[45]  Joe G Hollyfield,et al.  Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.

[46]  S. Perkins,et al.  Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. , 2008, Journal of molecular biology.

[47]  Anand Swaroop,et al.  Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. , 2009, Annual review of genomics and human genetics.

[48]  Michael Stumvoll,et al.  Antioxidants prevent health-promoting effects of physical exercise in humans , 2009, Proceedings of the National Academy of Sciences.

[49]  F. Guarner,et al.  Inflammatory Disease Processes and Interactions with Nutrition , 2009, British Journal of Nutrition.

[50]  P. Mitchell,et al.  Exogenous oestrogen exposure, female reproductive factors and the long‐term incidence of cataract: the Blue Mountains Eye Study , 2010, Acta ophthalmologica.

[51]  S. Connor,et al.  Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene , 2010, European journal of nutrition.

[52]  Imre Lengyel,et al.  Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration , 2011, Journal of molecular biology.

[53]  E. Agrón,et al.  Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. , 2011, Ophthalmology.

[54]  J. McCulley,et al.  Pilot, Prospective, Randomized, Double-masked, Placebo-controlled Clinical Trial of an Omega-3 Supplement for Dry Eye , 2011, Cornea.

[55]  J. McCulley,et al.  Erratum: Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye (Cornea (2011) 30 (308-314)) , 2011 .

[56]  Ami Miller,et al.  Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. , 2012, Immunobiology.

[57]  C. Lawton,et al.  Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2012 .

[58]  山城 健児 Age-Related Eye Disease Study 2 (特集 臨床において必要なサプリメントの知識) , 2012 .

[59]  E. Chew,et al.  Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. , 2012, Ophthalmology.

[60]  M. Gorin Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. , 2012, Molecular aspects of medicine.

[61]  Jennifer R. Evans,et al.  Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. , 2012, The Cochrane database of systematic reviews.

[62]  J. Vander Dietary ω-3 Fatty Acid and Fish Intake and Incident Age-Related Macular Degeneration in Women , 2012 .

[63]  安田 美穂 Age-Related Eye Disease Study と加齢黄斑変性におけるサプリメントガイドライン , 2012 .

[64]  E. Agrón,et al.  Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. , 2013, JAMA ophthalmology.

[65]  Ivana K. Kim,et al.  CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. , 2013, Ophthalmology.

[66]  Cynthia A. Toth,et al.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.

[67]  Gabriëlle H S Buitendijk,et al.  Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.

[68]  H. Hashemi,et al.  Short-term consumption of oral omega-3 and dry eye syndrome. , 2013, Ophthalmology.

[69]  M. Maciel Diet and age-related macular degeneration , 2016 .